NeuroDiscovery AI
NeuroDiscovery AI is a pioneering company revolutionizing neurological care and research through its AI-powered platform and one of the largest US neurological datasets with over 5 million de-identified patient records. The company integrates extensive multimodal data including EHRs, medical imaging, and multi-omics to provide advanced AI analytics that generate real-world evidence, accelerate patient recruitment for clinical trials, and discover novel biomarkers. Their proprietary technologies include the world's first neurology-specific large language model (NeuroLLM™), knowledge graphs, topological data analysis, and deep learning for imaging. NeuroDiscovery AI serves academic researchers, clinicians, and life sciences companies, offering scalable, secure, and HIPAA-compliant data solutions that support regulatory submissions and improve treatment outcomes. With partnerships across 470+ leading neurology providers and a focus on diseases like multiple sclerosis, Parkinson's, and Alzheimer's, the company is positioned as a leader in neurology AI-driven insights and clinical trial optimization.
NeuroDiscovery AI
NeuroDiscovery AI is a pioneering company revolutionizing neurological care and research through its AI-powered platform and one of the largest US neurological datasets with over 5 million de-identified patient records. The company integrates extensive multimodal data including EHRs, medical imaging, and multi-omics to provide advanced AI analytics that generate real-world evidence, accelerate patient recruitment for clinical trials, and discover novel biomarkers. Their proprietary technologies include the world's first neurology-specific large language model (NeuroLLM™), knowledge graphs, topological data analysis, and deep learning for imaging. NeuroDiscovery AI serves academic researchers, clinicians, and life sciences companies, offering scalable, secure, and HIPAA-compliant data solutions that support regulatory submissions and improve treatment outcomes. With partnerships across 470+ leading neurology providers and a focus on diseases like multiple sclerosis, Parkinson's, and Alzheimer's, the company is positioned as a leader in neurology AI-driven insights and clinical trial optimization.